Results 21 to 30 of about 3,524,198 (392)
Novel antifungal agents in clinical trials
F1000Research, 2021 Invasive fungal diseases due to resistant yeasts and molds are an important and increasing public health threat, likely due to a growing population of immunosuppressed hosts, increases in antifungal resistance, and improvements in laboratory diagnostics.
S. Jacobs +2 more
semanticscholar +1 more source
Biocontrol Ability and Action Mechanism of Starmerella bacillaris (Synonym Candida zemplinina) Isolated from Wine Musts against Gray Mold Disease Agent Botrytis cinerea on Grape and Their Effects on Alcoholic Fermentation [PDF]
, 2016 Gray mold is one of the most important diseases of grapevine in temperate climates. This plant pathogen affects plant growth and reduces wine quality. The use of yeasts as biocontrol agents to apply in the vineyard have been investigated in recent years ...
Bovo, Barbara +7 more
core +13 more sources
Drug repurposing strategies in the development of potential antifungal agents
Applied Microbiology and Biotechnology, 2021 The morbidity and mortality caused by invasive fungal infections are increasing across the globe due to developments in transplant surgery, the use of immunosuppressive agents, and the emergence of drug-resistant fungal strains, which has led to a ...
Qian Zhang +4 more
semanticscholar +1 more source
Saudi Pharmaceutical Journal, 2023 Human pathogenic fungi are responsible for causing a range of infection types including mucosal, skin, and invasive infections. Life-threatening and invasive fungal infections (FIs) are responsible for mortality and morbidity, especially for individuals ...
Osama A. Madkhali
doaj +1 more source
Molecules, 2021 Essential oils (EOs) are known to have varying degrees of antimicrobial properties that are mainly due to the presence of bioactive compounds. These include antiviral, nematicidal, antifungal, insecticidal and antioxidant properties.
Aswir Abd Rashed +3 more
doaj +1 more source
Antifungal Resistance and the Role of New Therapeutic Agents
Current Infectious Disease Reports, 2022 Advances in health care over time have led to an evolution in the epidemiology of invasive fungal infections. There is an increasing concern for antifungal resistance and emergence of less common fungal species for which optimal therapies are not well ...
Ashley Logan, A. Wolfe, J. Williamson
semanticscholar +1 more source
Novel Natural and Synthetic Anticandidal Therapeutic Peptides to Combat Drug-Resistant Infections
Medical Sciences Forum, 2023 Candida species are considered as common flora of the healthy human mycobiome and occur on skin, mucosal surfaces of gastrointestinal and genitourinary tracks. Pathogenic Candida spp., reported to cause skin, vaginal and oral infections. Extensive use of
Deepika Sharma
doaj +1 more source
Aspiring Antifungals: Review of Current Antifungal Pipeline Developments
Journal of Fungi, 2020 Invasive fungal infections are associated with significant morbidity and mortality, and their management is restricted to a variety of agents from five established classes of antifungal medication.
Thomas J. Gintjee +2 more
doaj +1 more source
Antifungal Combinations in Dermatophytes
Journal of Fungi, 2021 Dermatophytes are the most common cause of fungal infections worldwide, affecting millions of people annually. The emergence of resistance among dermatophytes along with the availability of antifungal susceptibility procedures suitable for testing ...
Lucia Brescini +3 more
doaj +1 more source
Use of antifungal drugs in hematology
Revista Brasileira de Hematologia e Hemoterapia, 2012 Invasive fungal disease represents a major complication in hematological patients. Antifungal agents are frequently used in hematologic patients for different purposes.
Marcio Nucci
doaj +1 more source